Are treatment response assessment maps (TRAMs) and ¹⁸ F-choline positron emission tomography the future of central nervous system lymphoma imaging?

Br J Haematol. 2021 Oct;195(1):e116-e119. doi: 10.1111/bjh.17632. Epub 2021 Jun 9.

Authors

Jie-Ying Kowa¹, Thomas Millard¹, Anouchka Goldman¹, Rajaei K Sharma², Ayoma Attygalle¹, Preethika Mahalingam¹, Kirsty Marshall¹, Liam Welsh¹, Su Li¹, Andrew Mackinnon¹, Philip Rich¹, Emma Nicholson¹, Sunil Iyengar^{1

3}, Dima El-Sharkawi¹, Ian Chau¹, David Cunningham¹, Bhupinder Sharma¹

Affiliations

¹ The Royal Marsden NHS Foundation Trust, London, UK.
² College of Medicine and Health, University of Exeter, Exeter, UK.
³ The Institute of Cancer Research, London, UK.

PMID: 34109610
DOI: 10.1111/bjh.17632

No abstract available

Keywords: CNS lymphoma; Choline-PET; TRAMs.

Publication types

Comparative Study
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Central Nervous System Neoplasms / diagnostic imaging*
Central Nervous System Neoplasms / pathology
Cerebellar Neoplasms / diagnostic imaging
Cerebellar Neoplasms / pathology
Choline / analogs & derivatives
Fluorine Radioisotopes
Fluorodeoxyglucose F18
Humans
Lymphoma, Large B-Cell, Diffuse / diagnostic imaging
Lymphoma, Non-Hodgkin / diagnostic imaging*
Lymphoma, Non-Hodgkin / pathology
Magnetic Resonance Imaging / methods*
Multimodal Imaging / methods*
Neuroimaging / methods*
Positron Emission Tomography Computed Tomography / methods
Radiopharmaceuticals

Substances

Fluorine Radioisotopes
Radiopharmaceuticals
Fluorodeoxyglucose F18
fluorocholine
Fluorine-18
Choline